Lanova Medicines Zhejiang Co., Ltd.

This study is testing an experimental drug called LM-302 against standard treatments for people with advanced stomach or gastroesophageal junction cancer that has a specific marker (CLDN18.2). It is for patients whose cancer has continued to grow after trying at least two other t…